SEC Form 3 · accession 0000899243-17-017473
AILERON THERAPEUTICS INC · ALRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph A., Yanchik III
Officer — See Remarks · Director · 10% Owner
Period of report
Jun 28, 2017
Accepted (ET)
Jun 28, 2017 · 7:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 123,796 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.30 | holding | — | — | — | — | Jun 25, 2019 | Common Stock | 5,075 | — | D |
| Stock Option (right to buy)F1 | $1.30 | holding | — | — | — | — | Jun 25, 2019 | Common Stock | 5,998 | — | D |
| Stock Option (right to buy)F1 | $1.30 | holding | — | — | — | — | Jun 25, 2019 | Common Stock | 139,773 | — | D |
| Stock Option (right to buy)F2 | $5.47 | holding | — | — | — | — | Jun 18, 2025 | Common Stock | 329,334 | — | D |
| Stock Option (right to buy)F3 | $5.77 | holding | — | — | — | — | Mar 2, 2027 | Common Stock | 159,001 | — | D |
Explanation of responses
- F1These options are fully vested.
- F2These options were granted on June 18, 2015 and vest as to 2.0833% of the shares in equal monthly installments through June 18, 2019.
- F3These options were granted on March 2, 2017 and vest as to 2.0833% of the shares in equal monthly installments through March 2, 2021.
Remarks
President and Chief Executive Officer and Director Exhibit Index: 24.1 Power of Attorney